Recommended Articles

The clearest early demonstration came in 1999, when researchers Karine Spiegel, Rachel Leproult, and Eve Van Cauter published a study in The Lancet that has since become a reference point for the field. They took 11 healthy young men and restricted their time in bed to 4 hours a night for six consecutive nights, then compared their metabolic function to a "recovery" condition where the same men got 12 hours in bed a night for six nights.

The difference was measurable and statistically significant: glucose tolerance was clearly lower in the sleep-debt condition than in the fully rested one. In other words, after less than a week of short sleep, these young, healthy men's bodies were noticeably worse at clearing glucose from their bloodstream: a core marker of insulin resistance. The study also found disruptions to thyroid hormone levels, suggesting sleep debt doesn't just nudge one system off balance, but touches the body's broader hormonal regulation. The researchers noted this was striking given that, at the time, sleep debt was widely assumed to have no real health consequences.

A single small study is a starting point, not a verdict, which is why it matters that the finding has been replicated with more rigorous methods since. In 2010, Orfeu Buxton and colleagues at Brigham and Women's Hospital ran a tightly controlled 12-day inpatient study with 20 healthy men. Participants spent 10 hours a night in bed for over a week (a fully rested baseline), then had that cut to 5 hours a night for seven nights, with diet and activity held constant throughout.

Using both an intravenous glucose tolerance test and the euglycemic-hyperinsulinemic clamp (which is considered the gold-standard method for measuring insulin sensitivity), the researchers found insulin sensitivity dropped by roughly 20% on one measure and 11% on the other after just a week of restricted sleep, both statistically significant reductions. Because the clamp technique is harder to confound than earlier methods, this result carried real weight in confirming that sleep restriction itself, not some other lifestyle factor, was driving the change.

Taken together with other work from the same research group, sleep scientists now describe insufficient sleep as a genuine, independent risk factor for insulin resistance and type 2 diabetes. It is not merely a minor contributor, but a mechanism worth treating with the same seriousness as diet or activity level, especially given how common voluntary sleep curtailment has become in modern life.

Sleep restriction doesn't just interfere with how your body processes glucose directly, it also scrambles the hormones that tell you when you're hungry and when you've had enough. In a related study, the same Van Cauter research group found that healthy young men who had their sleep curtailed showed measurable drops in leptin (a hormone that signals fullness) alongside increases in ghrelin (a hormone that signals hunger). These shifts weren't just numbers on a lab report. They correlated with the men actually reporting increased hunger and appetite.

That combination matters because it creates a second pathway toward metabolic trouble. Even if someone's glucose handling weren't affected directly, a consistent hormonal push toward eating more, particularly toward energy-dense food, can independently drive the weight gain that worsens insulin resistance over time. In other words, not getting enough sleep can end up working against metabolic health from two directions at once.

Lab studies are useful because they isolate cause and effect, but they involve small samples in artificial settings. The natural next question is whether the same pattern shows up in the general population. The short answer is: it does. A widely cited analysis from the Sleep Heart Health Study, led by Daniel Gottlieb and colleagues, looked at sleep duration and glucose metabolism in a large community sample. Compared with people sleeping 7 to 8 hours a night, those sleeping 5 hours or less had roughly two and a half times the odds of having diabetes. Those sleeping 6 hours had about 66% higher odds, associations that held up even after excluding people with diagnosed insomnia or sleep-disordered breathing.

That last detail is important: it suggests the effect isn't limited to people with diagnosed sleep disorders. Ordinary, voluntary sleep restriction like staying up late, waking up early, treating sleep as the most flexible part of the schedule, appears to carry its own measurable metabolic cost across a general population, not just in a lab.